Targeting CD36-Mediated Lipid Metabolism by Selective Inhibitor-Augmented Antitumor Immune Responses in Oral Cancer.
Takaichi M, Tachinami H, Takatsuka D, Yonesi A, Sakurai K, Rasul MI, Imaue S, Yamada SI, Ruslin M, Yamazaki M, Tanuma JI, Noguchi M, Tomihara K.
Takaichi M, et al. Among authors: tomihara k.
Int J Mol Sci. 2024 Aug 30;25(17):9438. doi: 10.3390/ijms25179438.
Int J Mol Sci. 2024.
PMID: 39273384
Free PMC article.